Form 4 for LLY Lilly (Eli)
Accepted 2025-02-25 00:00:00 ET · period of report 2025-02-24 · accession 0001415889-25-005456 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ME | 2025-02-25 | 2025-02-24 | LLY | LILLY ENDOWMENT INC | 10% | S - Sale | $27,282.83 | -60.4K | 96.52M | -0.1% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-24 | S | D | 1,332 | $880.60 | 96,511,185 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $880.0764 to $880.975, inclusive. |
| 2 | Common | Common Stock | 2025-02-24 | S | D | 1,631 | $879.47 | 96,512,517 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $879.00 to $879.9383, inclusive. |
| 3 | Common | Common Stock | 2025-02-24 | S | D | 578 | $891.87 | 96,461,978 | D | — | — | (F15) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $891.6064 to $892.23, inclusive. |
| 4 | Common | Common Stock | 2025-02-24 | S | D | 1,818 | $878,401.00 | 96,514,148 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $878.00 to $878.95, inclusive. |
| 5 | Common | Common Stock | 2025-02-24 | S | D | 2,569 | $890.84 | 96,462,556 | D | — | — | (F14) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $890.553 to $891.532, inclusive. |
| 6 | Common | Common Stock | 2025-02-24 | S | D | 3,835 | $890.00 | 96,465,125 | D | — | — | (F13) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $889.49 to $890.4754, inclusive. |
| 7 | Common | Common Stock | 2025-02-24 | S | D | 4,230 | $888.98 | 96,468,960 | D | — | — | (F12) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $888.48 to $889.4464, inclusive. |
| 8 | Common | Common Stock | 2025-02-24 | S | D | 5,169 | $887.87 | 96,473,190 | D | — | — | (F11) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $887.41 to $888.3896, inclusive. |
| 9 | Common | Common Stock | 2025-02-24 | S | D | 5,754 | $886.86 | 96,478,359 | D | — | — | (F10) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $886.3769 to $887.37, inclusive. |
| 10 | Common | Common Stock | 2025-02-24 | S | D | 2,628 | $885.95 | 96,484,113 | D | — | — | (F9) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $885.3767 to $886.36, inclusive. |
| 11 | Common | Common Stock | 2025-02-24 | S | D | 1,700 | $884.64 | 96,486,741 | D | — | — | (F8) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $884.33 to $885.3106, inclusive. |
| 12 | Common | Common Stock | 2025-02-24 | S | D | 1,788 | $883.78 | 96,488,441 | D | — | — | (F7) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $883.285 to $884.27, inclusive. |
| 13 | Common | Common Stock | 2025-02-24 | S | D | 6,361 | $882.59 | 96,490,229 | D | — | — | (F6) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $882.22 to $883.215, inclusive. |
| 14 | Common | Common Stock | 2025-02-24 | S | D | 14,595 | $881.52 | 96,496,590 | D | — | — | (F5) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $881.22 to $882.2105, inclusive. |
| 15 | Common | Common Stock | 2025-02-24 | S | D | 6,444 | $877.31 | 96,515,966 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $877.00 to $877.99, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1), (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13), (14), and (15) to this Form 4. |